Literature DB >> 18564109

Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.

Jordi Sánchez-Delgado1, Xavier Calvet, Luis Bujanda, Javier P Gisbert, Llúcia Titó, Manuel Castro.   

Abstract

BACKGROUND: Cure rates of Helicobacter pylori infection with standard triple therapy are disappointingly low. A very effective, new sequential treatment schedule has recently been described. However, all studies published to date were performed in Italy; it is mandatory to confirm these results in other settings. AIM: To assess the cure rate and the acceptability of a new sequential treatment regimen through a pilot study.
METHODS: A hundred and thirty-nine patients (60% men, mean age 49.6 +/- 15.7 yr) were recruited from six centers. H. pylori status was assessed by histology, urease test or urea breath test. Sequential regime consisted of a 10-day treatment including a proton pump inhibitor (PPI) b.d. plus amoxicillin 1 g b.d. for the first 5 days, followed by a PPI b.d. clarithromycin 500 mg b.d. and metronidazole 500 mg b.d for the next 5 days. Eradication was determined 8 wk after the end of treatment by urea breath test or histology. Eradication rates were calculated both per protocol and by intention-to-treat.
RESULTS: Eradication was achieved in 117 out of 129 patients who returned for a follow-up test. The intention-to-treat eradication rate was thus 84.2% (95%CI: 77%-90%) and the per-protocol cure rate 90.7% (95%CI: 84%-95%). The treatment was well tolerated. Only 14 patients complained of mild side effects.
CONCLUSIONS: Sequential treatment seems highly effective for eradicating H. pylori.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564109     DOI: 10.1111/j.1572-0241.2008.01924.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

1.  Sequential Therapy for Helicobacter Pylori Eradication: The Time is Now!

Authors:  Dino Vaira; Angelo Zullo; Cesare Hassan; Giulia Fiorini; Nimish Vakil
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

2.  Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication.

Authors:  Xiao-Zhong Gao; Xiu-Li Qiao; Wen-Chong Song; Xiao-Feng Wang; Feng Liu
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

3.  Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.

Authors:  Jae Jin Hwang; Dong Ho Lee; Ae-Ra Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

4.  Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.

Authors:  Hyuk Soon Choi; Hoon Jai Chun; Sang Hoon Park; Bora Keum; Yeon Seok Seo; Yong Sik Kim; Yoon-Tae Jeen; Soon Ho Um; Hong Sik Lee; Chang Duck Kim; Ho Sang Ryu
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

5.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

Review 6.  Treatment of Helicobacter pylori infection: Current and future insights.

Authors:  Maliheh Safavi; Reyhaneh Sabourian; Alireza Foroumadi
Journal:  World J Clin Cases       Date:  2016-01-16       Impact factor: 1.337

Review 7.  Therapeutic management of recurrent peptic ulcer disease.

Authors:  Raymond S Tang; Francis K L Chan
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

8.  Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study.

Authors:  Hassan Seddik; Samir Ahid; Tarek El Adioui; Fatim-Zohra El Hamdi; Mohammed Hassar; Redouane Abouqal; Yahia Cherrah; Ahmed Benkirane
Journal:  Eur J Clin Pharmacol       Date:  2013-05-22       Impact factor: 2.953

9.  Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.

Authors:  Deng-Chyang Wu; Ping-I Hsu; Jeng-Yih Wu; Antone R Opekun; Chao-Hung Kuo; I-Chen Wu; Sophie S W Wang; Angela Chen; Wen-Chun Hung; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-03       Impact factor: 11.382

10.  Helicobacter  pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.

Authors:  Sotirios D Georgopoulos; Vasilios Papastergiou; Stylianos Karatapanis
Journal:  Gastroenterol Res Pract       Date:  2012-06-19       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.